| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |